Results 71 to 80 of about 303,909 (164)

Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection

Boletín Médico del Hospital Infantil de México
Background: HIV-infected children have a higher risk of presenting infections, including the hepatitis A virus (HAV). The inactivated HAV vaccine is immunogenic in immunocompetent hosts; however, there are insufficient studies on the duration of ...
José G. Vázquez-Rosales, Alejandra P. Melgoza-Salazar, Mariana G. Sámano-Aviña, Victoria E. Montaño-Luna, Ma. Rosalía Lira-Carmona, Fortino Solórzano-Santos   +5 more
doaj   +1 more source

Living donor domino liver transplantation in a hepatitis C virus/human immunodeficiency virus-coinfected hemophilia patient: a case report. [PDF]

Surg Case Rep, 2020
Yamamoto H, Sugawara Y, Sambommatsu Y, Shimata K, Yoshii D, Isono K, Honda M, Yamashita T, Matsushita S, Inomata Y, Hibi T.   +10 more
europepmc   +1 more source

Prevalence of Co-infection of Hepatitis B Virus and Hepatitis C Virus among Human Immunodeficiency Virus Patients on Antiretroviral Therapy at A Tertiary Care Centre, Eluru, Andhra Pradesh, India

Journal of Pure and Applied Microbiology
HIV, HBV, and HCV can form a pretty challenging trio when they coexist. Managing co-infection is crucial for the overall health of the individual, especially considering the potential impact on the liver.
V. Manjula, A. Krishnaveni, N. Viswabharathi, L. Jayalakshmi, M. Sasidhar, M. Jyothirmai   +5 more
doaj   +1 more source

Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C

Memorias do Instituto Oswaldo Cruz
With this study, the authors hope to alert clinicians regarding the presence of human T-cell lymphotropic virus type 1 and 2 (HTLV-1/-2) infections in patients with viral hepatitis B and C in Brazil.
Adele Caterino-de-Araujo, Fabiana Aparecida Alves, Karoline Rodrigues Campos, Marcílio Figueiredo Lemos, Regina Célia Moreira   +4 more
doaj   +1 more source

Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety. [PDF]

BMC Infect Dis, 2020
Omidkhoda A, Razi B, Arabkhazaeli A, Amini Kafi-Abad S.   +3 more
europepmc   +1 more source

Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus. [PDF]

Lancet Oncol
Karagas MR, Kaldor J, Michaelis M, Muchengeti MM, Alfaiate D, Argirion I, Chen X, Cunha C, Hantz S, Koljonen V, Laude HC, Lui WO, Nevels MM, O'Brien TR, Scheurer ME, Touze A, Wiemels JL, Benbrahim-Tallaa L, de Conti A, Facchin C, Madia F, Pasqual E, Wedekind R, Aguilera-Buenosvinos I, Clifford G, Deng X, Dongoran RA, Ezzemni S, Huang Y, Suonio E, Zhai Y, Mattock H, Schubauer-Berigan MK, Kunzmann AT.   +33 more
europepmc   +1 more source

Temporal Dynamics and Treatment Outcomes of Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Multicenter Retrospective Study from South Korea. [PDF]

Gut Liver
Jeong JY, Yu SJ, Park J, Choi NR, Kim SS, Yoon JH, Eun HS, Choi J, Yoon KT, Jung YK, Park SY, Gwak GY, Kim TY, Kim DY, Kim DY, Kim JH, Lee JW, Jang JW.   +17 more
europepmc   +1 more source

The prevalence of hepatitis B virus, human T-lymphotropic virus and human immunodeficiency virus in patients receiving blood transfusions in South Africa. [PDF]

Vox Sang
Willemse RJ, Grobler CJ, Murphy EL, Roubinian N, Colemen C, Machaba S, Vermeulen M.   +6 more
europepmc   +1 more source

[A leukocyte virus in human hepatitis].

Voprosy virusologii, 1971
A K, Shubladze, I F, Barinskiĭ, I V, Dement'ev, B V, Gushchin, A F, Bocharov   +4 more
openaire   +1 more source

Vaccines at the Heart of Hepatitis Elimination: Insights From the ESCMID Study Group for Viral Hepatitis (ESGVH). [PDF]

Liver Int
Săndulescu O, Şahin GÖ, Dudman SG, Said ZNA, Mondelli MU, ESCMID Study Group for Viral Hepatitis (ESGVH).   +5 more
europepmc   +1 more source